Cargando...
Biosimilars in paediatric inflammatory bowel disease
The introduction of biological treatments has changed disease outcomes for patients with inflammatory bowel disease. Biologicals have high efficacy, and can induce and maintain remission after failed responses to conventional immunosuppressive and/or steroid therapy. The increasing occurrence of sev...
Guardado en:
| Publicado en: | World J Gastroenterol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Baishideng Publishing Group Inc
2018
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148430/ https://ncbi.nlm.nih.gov/pubmed/30254406 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v24.i35.4021 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|